Prostaglandin E2-d4 MaxSpec® Standard
(Synonyms: Dinoprostoned4, PGE2d4) 目录号 : GC48686A quantitative analytical standard guaranteed to meet MaxSpec identity, purity, stability, and concentration specifications
Cas No.:34210-10-1
Sample solution is provided at 25 µL, 10mM.
Quality Control & SDS
- View current batch:
- Purity: >95.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
Prostaglandin E2-
PGE2-d4 MaxSpec® standard is a quantitative grade standard of PGE2-d4 that has been prepared specifically for mass spectrometry or any application where quantitative reproducibility is required. The solution has been prepared gravimetrically and is supplied in a deactivated glass ampule sealed under argon. The concentration was verified by comparison to an independently prepared calibration standard. This PGE2-d4 MaxSpec® standard is guaranteed to meet identity, purity, stability, and concentration specifications and is provided with a batch-specific certificate of analysis. Ongoing stability
testing is performed to ensure the concentration remains accurate throughout the shelf life of the product. Note: The amount of solution added to the vial is in excess of the listed amount. Therefore, it is necessary to accurately measure volumes for preparation of calibration standards. Follow recommended storage and handling conditions to maintain product quality.
1.Willis, A.L., and Cornelsen, M.Repeated injection of prostaglandin E2 in rat paws induces chronic swelling and a marked decrease in pain thresholdProstaglandins3(3)353-357(1973) 2.Jackson, G.M., Sharp, H.T., and Varner, M.W.Cervical ripening before induction of labor: A randomized trial of prostaglandin E2 gel versus low-dose oxytocinAm. J. Obstet. Gynecol.171(4)1092-1096(1994) 3.Robert, A., Schultz, J.R., Nezamis, J.E., et al.Gastric antisecretory and antiulcer properties of PGE2, 15-methyl PGE2, and 16,16-dimethyl PGE2. Intravenous, oral and intrajejunal administrationGastroenterology70(3)359-370(1976) 4.Arvind, P., Papavassiliou, E.D., Tsioulias, G.J., et al.Prostaglandin E2 down-regulates the expression of HLA-DR antigen in human colon adenocarcinoma cell linesBiochemistry34(16)5604-5609(1995) 5.Coleman, R.A., Smith, W.L., and Narumiya, S.International Union of Pharmacology classification of prostanoid receptors: Properties, distribution, and structure of the receptors and their subtypesPharmacol. Rev.46(2)205-229(1994)
制备储备液 | |||
1 mg | 5 mg | 10 mg | |
1 mM | 2.805 mL | 14.0252 mL | 28.0505 mL |
5 mM | 0.561 mL | 2.805 mL | 5.6101 mL |
10 mM | 0.2805 mL | 1.4025 mL | 2.805 mL |
第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量) | ||||||||||
给药剂量 | mg/kg | 动物平均体重 | g | 每只动物给药体积 | ul | 动物数量 | 只 | |||
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方) | ||||||||||
% DMSO % % Tween 80 % saline | ||||||||||
计算重置 |
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL saline,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。